Welcome to LookChem.com Sign In|Join Free

CAS

  • or

128833-92-1

Post Buying Request

128833-92-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128833-92-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 128833-92-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,8,3 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 128833-92:
(8*1)+(7*2)+(6*8)+(5*8)+(4*3)+(3*3)+(2*9)+(1*2)=151
151 % 10 = 1
So 128833-92-1 is a valid CAS Registry Number.

128833-92-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-cyclohexylpropane-1,2-diamine

1.2 Other means of identification

Product number -
Other names 1-(Cyclohexylmethyl)-1,2-ethanediamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:128833-92-1 SDS

128833-92-1Downstream Products

128833-92-1Relevant articles and documents

AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE

-

Page/Page column 142, (2009/10/06)

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain amino-ethyl-amino-aryl (AEAA) compounds which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 128833-92-1